We are live on
!
Find out more
Mercer Global Advisors Portfolio holdings
AUM
$67.6B
1-Year Est. Return
18.3%
This Fund
S&P 500
This Quarter
Est. Return
+6.92%
1 Year Est. Return
+18.3%
3 Year Est. Return
+51.43%
5 Year Est. Return
+55.53%
10 Year Est. Return
–
AUM
$59.9B
AUM Growth
+$10.8B
(+22%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.22%
Top 10 Holdings %
Top 10 Hldgs %
36.76%
Holding
2,762
New
514
Increased
1,374
Reduced
710
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$631M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$490M |
| 5 |
Meta Platforms (Facebook)
META
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$63M |
| 2 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$48.4M |
| 3 |
AbbVie
ABBV
|
+$32.6M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$31.6M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.83% |
| 2 | Financials | 3.85% |
| 3 | Consumer Discretionary | 2.66% |
| 4 | Communication Services | 2.45% |
| 5 | Healthcare | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Energy Vault
NRGV
$591M
| $36.3K | ﹤0.01% |
+12,238
| New | +$20.1K |
|
2602
Sana Biotechnology
SANA
$946M
| $35.8K | ﹤0.01% |
+10,086
| New | +$36.5K |
|
2603
Solitario Resources
XPL
$66.1M
| $34.9K | ﹤0.01% |
+50,000
| New | +$36.1K |
|
|
LPRO
2604
DELISTED
Open Lending Corp
LPRO
| $34.9K | ﹤0.01% |
16,526
+2,685
| +19% | +$6.07K |
|
|
LAZR
2605
DELISTED
Luminar Technologies
LAZR
| $34.6K | ﹤0.01% |
18,112
+1,280
| +8% | +$3.14K |
|
2606
Heron Therapeutics
HRTX
$96.8M
| $33.7K | ﹤0.01% |
+26,709
| New | +$42.3K |
|
|
MGF
2607
Aberdeen Government Markets Income Fund
MGF
$92.2M
| $32.3K | ﹤0.01% |
+10,339
| New | +$32K |
|
2608
CEMIG Ordinary Shares
CIG.C
$9.01B
| $30.7K | ﹤0.01% |
11,246
-5,309
| -32% | -$14.4K |
|
2609
Allogene Therapeutics
ALLO
$656M
| $29.8K | ﹤0.01% |
+23,998
| New | +$28.6K |
|
|
DHF
2610
BNY Mellon High Yield Strategies Fund
DHF
$174M
| $26.7K | ﹤0.01% |
10,307
-3,000
| -23% | -$7.76K |
|
|
CRDL
2611
Cardiol Therapeutics
CRDL
$157M
| $24.2K | ﹤0.01% |
22,600
| – | – |
|
|
URG
2612
Ur-Energy
URG
$517M
| $23.1K | ﹤0.01% |
+12,882
| New | +$17.5K |
|
2613
Research Frontiers
REFR
$16.3M
| $22.3K | ﹤0.01% |
14,000
| – | – |
|
2614
Cognition Therapeutics
CGTX
$88.3M
| $21.5K | ﹤0.01% |
15,951
-100
| -0.6% | -$136 |
|
2615
Fate Therapeutics
FATE
$300M
| $20.6K | ﹤0.01% |
+16,377
| New | +$17.7K |
|
2616
Hain Celestial
HAIN
$48.7M
| $20.4K | ﹤0.01% |
+12,924
| New | +$22K |
|
2617
Aclaris Therapeutics
ACRS
$835M
| $19.9K | ﹤0.01% |
10,460
+240
| +2% | +$418 |
|
|
PSTV
2618
DELISTED
Plus Therapeutics
PSTV
| $19.5K | ﹤0.01% |
+1,139
| New | +$14K |
|
2619
Oxbridge Re Holdings Ltd Warrant
OXBRW
| $19K | ﹤0.01% |
47,500
| – | – |
|
|
OLPX
2620
DELISTED
Olaplex Holdings
OLPX
| $18.8K | ﹤0.01% |
+14,314
| New | +$20.5K |
|
2621
Pacific Biosciences
PACB
$447M
| $17.9K | ﹤0.01% |
13,968
+1,581
| +13% | +$2.14K |
|
2622
LivePerson
LPSN
$27M
| $14.7K | ﹤0.01% |
+1,681
| New | +$23.6K |
|
2623
GameSquare
GAME
$36.6M
| $13.6K | ﹤0.01% |
+20,000
| New | +$19.7K |
|
2624
PDS Biotechnology
PDSB
$40.3M
| $12.6K | ﹤0.01% |
12,500
-10
| -0.1% | -$12 |
|
|
RNTX
2625
Rein Therapeutics
RNTX
$65.3M
| $12K | ﹤0.01% |
+10,461
| New | +$13.3K |
|
Similar funds
Mercer Global Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Mercer Global Advisors held 2,762 positions worth $59.9B, up 22% from $49.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mercer Global Advisors deployed $7.92B of net new capital in Q3 2025, opening 514 new positions and adding to 1,374 existing holdings. Its largest new stake was Apple: 6,050,013 shares worth $1.53B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 4.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $63M trimmed.
- Mercer Global Advisors's largest Q3 2025 buy was Apple: 6,050,013 shares worth $1.53B.
- Mercer Global Advisors added most to iShares Core US Aggregate Bond ETF in Q3 2025, an estimated $490M increase.
- Mercer Global Advisors's biggest Q3 2025 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $63M.
- Mercer Global Advisors fully exited Virtus Private Credit Strategy ETF in Q3 2025, selling an estimated $9.11M.
- Mercer Global Advisors's ten largest holdings make up 37% of its $59.9B portfolio in Q3 2025.
- Mercer Global Advisors opened 514 new positions and closed 129 in Q3 2025.
- Mercer Global Advisors's portfolio value rose 22% quarter-over-quarter to $59.9B.
Based on Mercer Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.